Gastroparesis (GP), defined as delayed gastric emptying in the absence of any mechanical obstruction, is a challenging clinical condition, mainly because of limited treatment options. Studies in animal models of delayed gastric emptying as well as patients with gastroparesis revealed depletion or ultrastructural changes of interstitial cells of Cajal (ICC) in the gastric tissue, recently termed ICC-opathy. ICC are the pacemakers of the gastrointestinal tract and are involved in the transmission of the neuronal signaling to the smooth muscles. Therefore, lack of ICC could be one explanation of delayed gastric emptying in gastroparetic patients. How frequently ICC changes are observed in gastroparesis is not yet clear. In this review, the data on gastric ICC counts and morphology in animal models and patients with gastroparesis are discussed. 
Introduction
Gastroparesis (GP), affecting up to 10 million individuals in the United States (US), is a relatively common gastrointestinal (GI) motility disorder and is defined as delayed gastric emptying without any mechanical obstruction. GP presents with upper GI symptoms such as nausea, vomiting, early satiety, postprandial fullness, bloating, and abdominal pain. The etiology of GP in the majority of cases are idiopathic (IP-GP), while many others are diabetic (DM-GP). 1 Based on the limited number of community or population studies, the age adjusted prevalence of IP-GP is 37.8 and 9.6 in 100 000 women and men, respectively. 2 The average cumulative incidence of GP during a 10 year period was 5.2% in type 1 DM, 1% in type 2 DM, and 0.2% in the controls. 3 Another study in a more representative population indicated a higher prevalence for DM-GP, estimating that approximately 165 000 patients with type 1 DM (14% of US patients with type 1 DM) and 2.1 million patients with type 2 DM (9.4%) were actually seeking treatment for their GP symptoms. 4 Patients with GP suffer from nutritional deficiencies and metabolic consequences as well as impaired social activities and quality of life. Hospitalizations due to GP increased by 2.4 fold in the US between 1995 and 2004. Moreover, work absenteeism, high unemployment rate and lower household income are variably associated with GP. 5, 6 Treatment of GP is based on alleviating symptoms, enhancing gastric emptying, correcting nutritional abnormalities and targeting the underlying causes, although it is usually challenging and often suboptimal. 1 Therefore, finding new drug and device targets for the treatment of this chronic disorder is a research priority in the field of GI motility disorders.
Identifying disease biomarkers may help us in developing better strategies for the diagnosis and management of the gastroparetic patients. These biomarkers could provide a rationale for an individualized approach which could be linked to the treatment outcome and prognosis in these patients. A potential biomarker in this area is the interstitial cells of Cajal (ICC).
ICC are mesenchymal cells acting as the pacemakers for the generation of slow waves in the GI tract (Fig. 1) . Their electrical activity defines the frequency of the rhythmic contraction. ICC are involved in GI motor activities, as conduits for muscular innervation and are possibly transmitters of sensory innervation in the GI tract. ICC are distributed throughout the GI tract from the esophagus to the internal anal sphincter and within different layers specifically submucosal (ICC-SM), myenteric plexus (ICC-MP), intramuscular (ICC-IM), and ICC deep muscular plexus (ICC-DMP). Two major distributions of ICC which determine gastric motility are: (1) ICC-IM and (2) ICC-MP. [7] [8] [9] [10] Both ICC count and morphology are important in gastric electrophysiology and as a biomarker for GI motility disorders. ICC express C-Kit, a receptor tyrosine kinase, which is necessary for the development and maintenance of ICC phenotype. Therefore, the population and morphology of ICC can be studied by ICC markers including C-Kit ( Fig.1 ) and anoctamin-1 (ANO1). 7, 9, 11 Loss of ICC, identified by the loss of C-Kit or ANO1 immunostaining, has been recognized in different GI disorders such as slow transit constipation 12 and inflammatory bowel disease, 13, 14 and there is a relatively substantial and growing body of literature on the loss or altered morphology of ICC in GP. [15] [16] [17] [18] In order to understand the role of ICC in the pathophysiology of GP, it is crucial to know the normal distribution and population as well as the structure of these cells in the stomach. Therefore, the aim of this systematic review was to explore research articles on the distribution, population and morphology of ICC in the pathogenesis of GP.
M ethodology
To identify clinical and basic studies on ICC in GP or animal models of GP, PubMed was systematically searched in February 2015 with the search terms shown in Table 1 .
In total, 453 studies were retrieved for the evaluation. The articles were examined through reviewing their titles and abstracts. Full-text of the relevant abstracts and their list of references were fully evaluated. Studies which compared the population of ICC in the gastric tissue of gastroparetic patients or animal models of delayed gastric emptying compared to controls were included and reviewed. In addition to this, we examined studies on the structure (or ultrastructure) of ICC in GP. Studies which were not in English were excluded. 
Results

Gastroparesis and Interstitial Cells of Cajal in Animal Models
Animal models of delayed gastric emptying have been used for the assessment of the role of ICC in the pathophysiology of GP. Neuronal nitric oxide synthase-deficient (nNOS −/− ) mice and diabetic animals (eg, Streptozotocin treated rats, nonobese diabetic [NOD] mice, and ob/ob mouse model of obesity) are well-known animal models of GP. [19] [20] [21] [22] The results observed in ICC deficient mice or rats were contradictory. They have been used both as a model of duodenogastric reflux based on the presence of a hypotensive pyloric sphincter, as well as delayed gastric emptying mimicking GP. 19, 23 Ultrastructural changes of ICC as well as ICC depletion have been observed in diabetic animal models. Two recent studies by Chen et al 24, 25 showed that diabetes induced by streptozotocin in rats delays gastric emptying, decreases contractions of the antral strips, and decreases ICC-IM, ICC-MP, and ICC-SM counts in the antrum. In addition, the long processes of ICC-IM were impaired and C-Kit positive cells had incomplete membranes, fractured and shorten processes, slender cell bodies, swollen mitochondria, disrupted cristaed and condensed chromatin. Moreover, significant apoptosis was observed in ICC-IM, ICC-MP, and ICC-SM. 24, 25 The restoration of ICC counts as well as their morphology after electroacupuncture may explain the effects of this treatment strategy on gastric emptying in this animal model. 24, 25 Mogami et al 26 also showed ICC depletion in the whole stomach and more prominently in the antrum, 8 weeks after injecting streptozotocin to rats. In another study ICC were depleted in the proximal part of the stomach in diabetic rats. 27 Similar to changes observed with electroacupuncture, 24, 25 mRNA expression of KIT in the stomach tissue was increased after treatment with Curcumin, the main active component of the spice turmeric. 27 Wang et al 28 reported that the density of ICC-IM and ICC-SM was reduced by 46.4% and 26.7%, respectively in the antrum of streptozotocin induced diabetic rats. In addition, Long et al 29 showed depleted antral ICC and ultrastructural changes such as decreased number of gap junctions of ICC in the antrum and damaged ICC organelles of the diabetic rats. The mouse model of streptozotocin induced diabetes also presents with gastric ICC depletion. 30 The NOD mice present with reduced motor neurotransmission, delayed gastric emptying, and impaired electrical pace-making. ICC are greatly reduced in their antrum, and the normal associations between these cells and enteric nerves are affected. 31 In genetically ICC depleted (Ws/Ws) rats, ICC loss is not always directly translated to delayed gastric emptying. Zhang and colleagues 23 showed that gastric emptying is delayed and ICC-IM are depleted in the antrum of Ws/Ws rats, suggesting a possible correlation between ICC count and gastric motor function, while some other studies reported pyloric incompetency and bile reflux in this same animal model. 19, 32, 33 As discussed above, most of the animal studies have shown correlation between ICC especially in the antrum with GP, but studies on the pyloric ICC are scarce and controversial. Wang et al 34 showed that ICC-MP is naturally depleted in the pylorus of mouse and rat and the slow waves are lost in this region. On the other hand, based on a study by Seki and Komuro, 35 ICC are 24, 25 Diabetic densely distributed throughout the cardia, fundus, and the squamous epithelial portion of the corpus as well as the pylorus of mice. Available data on the ICC count in the diabetic and genetical animal models of GP are summarized in Table 2 .
Gastroparesis and Interstitial Cells of Cajal in Human
Interstitial cells of Cajal in the gastric body Depletion of ICC in the gastric body has been shown in different studies. For example, O'Grady et al 36 showed substantial ICC loss in the gastric body circular muscle of 9 gastroparetic patients (6 DM-GP and 3 IP-GP) compared to controls. In another study, the Gastroparesis Clinical Research Consortium (GpCRC) which consists of a network of 8 medical centers and one data coordinating center collaborating to perform research on GP, assessed full-thickness gastric body biopsies from 20 patients with ID-GP and 20 patients with DM-GP who were undergoing surgery for the placement of a gastric stimulator as well as 20 controls. ICC populations were significantly decreased in both diabetic and idiopathic gastroparetic groups compared to the controls, with no difference in ICC loss between diabetic and idiopathic GP. 16 In a further clinical investigation by the GpCRC, the ICC population was lower in the gastric body of diabetic and idiopathic patients but the depleted ICC count correlated with the rate of gastric emptying of an isotope labeled meal in only the diabetic gastroparetic subgroup. There were no differences between the individual symptoms including nausea, vomiting and bloating as well as the GP cardinal symptom index score (GCSI) based on either low or normal gastric body ICC counts. 15 Mazzone et al 37 also showed fewer ICC in the gastric body smooth muscle in patients with diabetic GP compared to controls based on both C-Kit and ANO1 staining. In a case report, 2 patients with DM-GP, one with well controlled diabetes and the other one with poorly controlled diabetes, ICC counts were compared. Interestingly, the well-controlled patient had a normal ICC count; however, ICC-IM were depleted in the gastric body of the poorly controlled patient. Both patients were severely symptomatic. The conclusion was the severity of GP could not be predicted by the status of the ICC population in these 2 patients. 10 Another case report, also showed loss of ICC network in the fundus, body and antrum of a severe ID-GP patient. 38 Ultrastructural changes such as wrinkling of the nucleus, karyorrhexis, pyknosis, and heterochromatin as well as decreased cytoplasmic volume, diffuse swelling of the cytoplasm, and dilatation of the endoplasmic reticulum have also been described in the gastric ICC of diabetic patients compared to controls. 39 In gastroparetic patients where the ICC count may not be different compared to the controls, the ultrastructure of ICC in the gastric body might be abnormal. Indeed, apoptotic features and defects in the connection between ICC and nerve endings, smooth muscle and other ICC are observed in GP. These changes are more prominent in IP-GP compared to DM-GP. 40 
Interstitial cells of Cajal in the gastric antrum
Iwasaki et al 41 showed depletion of ICC, nNOS and substance P in the antrum of diabetic patients. In another study, full-thickness antral biopsies in 28 patients (14 diabetic and 14 idiopathic) with refractory GP undergoing surgical laparotomy for the placement of a gastric electric stimulator were compared to 8 controls who were undergoing gastric resection for other reasons. A significant reduction in the number of ICC in the myenteric plexus in both diabetic and idiopathic gastroparetic patients compared to controls was observed, although there was no significant difference in the number of ICC in the outer longitudinal and inner circular muscle layers. 17 Our group studied 41 adult patients with refractory GP (34 diabetic, 5 idiopathic, and 2 postsurgical) who were referred for gastric electrical stimulation (GES) and 10 control patients who underwent gastric resection or gastrectomy for reasons other than GP. Full-thickness antral biopsies were stained for C-Kit and the number of ICC were analyzed. The number of ICC was depleted in 15 patients (37%) and was normal in 26 patients (63%). No difference was found between the baseline symptom severities in ICC normal versus ICC depleted group. However, electrogastrography showed that patients with depleted ICC had significantly less numbers of normal slow waves and more tachygastria compared to those with adequate ICC population. ICC count did not significantly correlate with etiology, age, gender, symptom severity of GP and gastric emptying. However, severely depleted ICC was associated with a poorer symptomatic response to GES. 18 Most recently, a study in 26 gastroparetic patients who were referred for the insertion of a gastric electric stimulator (18 diabetic and 8 idiopathic) showed antral ICC depletion in 11 patients (42%), and a trend toward decreased gastric emptying of an isotope labeled solid meal in patients with lower ICC population (P < 0.07). 42 Studies on human gastric ICC counts and GP are summarized in Table 3 .
Interstitial cells of Cajal in the gastric pylorus
Studies on the pyloric ICC in GP are sparse. A recent preliminary study showed that ICC are depleted in the pyloric smooth muscles of 61% of both DM-GP and ID-GP patients who required a GES. 43 
Discussion and Conclusion
The animal studies consistently demonstrate that ICC are depleted in diabetic gastroparetic models. On the other hand, data on animals with genetically depleted ICC are contradictory in that ICC loss does not always accompany delayed gastric emptying. Interestingly, it appears that ICC loss and abnormal morphology may be reversed by treatment in animals.
In the human literature, although the quality and the quantity of the studies concerning the role of ICC in the pathogenesis of GP may vary; gastric ICC are depleted in up to 50% of patients with either ID-GP or DM-GP.
More specifically, in the human gastric body, decreased ICC population as well as ultrastructural changes of ICC have been observed and there was correlation between depleted ICC population and gastric emptying in diabetics.
In the antrum which is the site of major gastric contractility and trituration of food, there were correlations between the clinical findings and the ICC population (Fig. 2) .
Another entity which should be discussed here is gastroparesis-like syndrome. A recent article on gastroparesis-like syndrome indicated that this syndrome is associated with both deple- tion and mild ultrastructural abnormalities of the ICC in the stomach. 44 The hypothesis that gastroparesis like syndrome is a part of a spectrum of the same condition as GP needs to be addressed in future studies. 45 Whether ICC can be used as the predictor of therapeutic response in GP is not yet clear. Future studies should address which ICC subtypes are the key players in the development of GP as well as the mechanisms whereby ICC are affected. Maybe, larger animals would be more helpful in differentiating and studying ICC counts and morphology based on different gastric segments. In addition, animal models should emphasize the effect of gender in the development of GP, since 80% of gastroparetic patients are females. Future animal studies should also include drug induced GP as a model (ie, Is the medication toxic to the ICC?) vs post-viral GP and the progressive injury model of diabetes.
Whether ultrastructural and functional changes of ICC are more important than ICC count needs further investigation. Moreover, future studies should address whether ICC loss is an absolute finding, or is an indicative of a more generalized neuropathic process. Another important observation is whether ICC-opathy is a cause, a consequence or an epiphenomenon accompanying GP.
The current literature for the analysis of ICC is limited to patients with severe symptoms who underwent surgery (eg, insertion of electrical stimulation or J-tube). It is not clear whether ICC counts and ultrastructure are also changed in patients with mild or moderate GP since in these patients gastric full thickness biopsies have not been studied. Moreover, the importance of pyloric ICC in the development of GP needs more of focus in future multi-center studies with adequate sample size.
Future research in humans will benefit by a recent breakthrough in obtaining nonsurgical gastric biopsies through percutaneous endoscopically assisted transenteric full-thickness gastric biopsy, 46 or antral muscularis propria biopsies utilizing endoscopic ultrasound guidance. 47 This ability to have nonsurgical access to smooth muscles will facilitate better understanding of ICC in different clinical settings including their role in the development of GP and as the predictors of response to medical therapies. For now, the body of evidence we have summarized supports an overall role for ICC in the pathophysiology of GP.
